Increased catalytic activity of PR3 in COPD results in a high catalytic turnover of elastin in pulmonary parenchyma in relation to impaired lung elasticity and emphysema (Gudmann et al., 2018). This evidence concerns the gene PRTN3 and pulmonary emphysema.